Innovation Office University of Basel ’s Post

Yesterday marked Day 1 of HealthTech For Care’s Health Tech Innovation Days (#HTID6), offering Pulse Edge a chance to connect with global thought leaders in #healthtech. Some striking insights: 📌 #France, a 'territory of #innovation', boasts over 2600 health tech companies, generating $1.4 billion in 2022. 📌 France has attracted the most foreign investment in Europe since 2019. 📌 60% of French development is in biomedicines, the second-largest pipeline globally. 📌 #Financing remains a challenge: less ambitious projects (lower risk/reward), 'more mature' financing (increased funding per raise, but among fewer raises) and challenging valuations and deals. 📌 Biotech financing shows positive signs: 20% increase in S&P Biotech ETF since April, and increased M&As in 2024. Further improvements are likely next year given macro-economic trends and impact from policy tools. 📌 #Opportunities for value-creating technologies include (1) increased risk-taking and (2) providing more equity to long-term investors (“𝘪𝘵’𝘴 𝘣𝘦𝘵𝘵𝘦𝘳 𝘵𝘰 𝘰𝘸𝘯 𝘢 𝘴𝘮𝘢𝘭𝘭𝘦𝘳 𝘱𝘢𝘳𝘵 𝘰𝘧 𝘴𝘰𝘮𝘦𝘵𝘩𝘪𝘯𝘨 𝘣𝘪𝘨 𝘵𝘩𝘢𝘯 𝘢 𝘭𝘢𝘳𝘨𝘦 𝘱𝘪𝘦𝘤𝘦 𝘰𝘧 𝘴𝘰𝘮𝘦𝘵𝘩𝘪𝘯𝘨 𝘴𝘮𝘢𝘭𝘭") Biotech company advice from industry leader Marc de Garidel: 🚀 'Focus and speed' are critical. Focus on one drug then expand to other indications. Be resilient but know when to stop. 🚀 Differentiation vs. standard of care is key. Start your strategic trial design in Phase 2 and map a path to both registration and market access. 🚀 Work with top tier investors (despite the challenge). 🚀 Ensure the right board: complementary skills and challenge. 🚀 Focus on the US market (and hire accordingly). 🚀 Have an exit strategy. Future perspectives for health tech innovation from Gabriela Apiou-Sbirlea, Robert Tepper and timothy ferris: 💡 New technologies have exploded in the last 20 years. 💡 Innovation now emerges from a variety of sources (pharma, small biotech and academic centers), requiring collaboration. Opportunities exist to 'cross-train' in discovery and development as well as leverage experience from biopharma leaders. 💡 'Health info technologies' can lower costs on delivery side, aiding affordability for new innovation. However, due to digitization burden, such technologies have slowed delivery of care. This is expected to reverse rapidly going forward. 💡 AI will impact clinical decision-making via discrete efficiencies (where AI performs better) and via decision support. Expect a transition period. 💡Expect also new ways to deliver care, such as digital therapeutics in mental health. I'm greatly looking forward to Day 2! Thanks to Pierre Courteille and Sophie Villedieu for the opportunity for Pulse Network to partner with this event. #curiousminds #networking #lifesciences

Healthcare Innovation News for the week of November 20, 2024: · Mass General Brigham Leads Health Systems in Launching Collaborative to Evaluate and Rank Healthcare AI Tools · Jupiter Bioventures, co-founded by biotech entrepreneurs Nathaniel David and Norman Sharpless, has secured $70 million in initial funding from a syndicate including Mission BioCapital and Mayo Clinic to establish cancer-focused biotech startups. · Stepful Raises $31.5M Series B Led by Oak HC/FT, with ECMC Education Impact Fund Among Investors · Aegis Ventures Expands Digital Health Consortium with UPMC Enterprises and Vanderbilt Health, Strengthening Innovation in Healthcare · Eli Lilly and Company Launches $42 Million Digital Health Innovation Hub in Singapore, Featuring AI-Powered Platform and Smart Toilet Technology · New England Venture Capital Association's 12th Annual NEVYs Awards Returns with Survivor Theme, Celebrating New England's Innovation Excellence · Cincinnati Children's Hospital Launches Innovation Incubator to Tackle Clinical Challenges · Cleveland Clinic's 2024 Innovation Challenge Awards $100,000 Grant for Groundbreaking Bacterial Prevention Research · American Heart Association and MATTER Launch Heart of Innovation HBCU Challenge to Address Healthcare Disparities · Biomedical Advanced Research and Development Authority (BARDA) and MATTER Launch Paratus Digital Health Accelerator: Seeking Innovative Solutions for Health Security Preparedness · Mass General Brigham Launches Healthcare AI Challenge to Evaluate AI Technologies in Real-World Scenarios · Duke Institute for Health Innovation Seeks Dynamic Program Coordinator to Drive Healthcare Innovation Healthcare Development & Innovation Group (HDIG) Search/HDIG Partners/HDIG Funds HDIG is an ecosystem to make healthcare innovation more efficient. HDIG Search: a searchable database of hospital healthcare venture, innovation centers, tech transfer offices. It assists you in understanding the landscape of partnerships, performance, and contacts. Early-stage companies use it to find partners and funding for their pilots, or even professional firms or tech companies depending on their needs. HDIG Partners: Consulting & valuable resources for hands on insight, valuation & improvement. HDIG Funds: Capital investment into pilots & start-ups Launched with nearly 10,000 companies, hospitals, & funds, get full access for a special subscription & you can cancel at anytime, this would include building your profile. Learn more about our Acceleration Pilot Program, paid pilots, reverse studio model & other research & services. Welcome new subscriber partners: Mesolv LLC and Celebrace HDIG will be attending these events: · Bamberg Health Innovation – Atlanta, GA, Dec 3 · J.P. Morgan - San Francisco, Jan, 13-15 #healthcareinnovation #hospitalinnovation #innovationcenters #HDIG #venturestudios #startups

It was fascinating to get a glimpse into the world of a pioneering leader and visionary - Prof. Yitzhak Kreiss, CEO of Sheba, who is leading an adaptive strategic change and practically transforming medical centers into economic growth engines by embedding DNA for the development of transformation, innovation, and technological entrepreneurship, while deeply connecting with the international high-tech industry ecosystem. Under his leadership and that of Prof. Eyal Zimlichman, CEO of ARC, Sheba has become a global impact on healthcare, working on investments and integrating startups into professional activities in hospitals worldwide, establishing a center for integrating generative artificial intelligence in medicine, developing the future hospital in the Negev, and more. On Thursday, I attended the annual international conference of ARC Innovation , the innovation and entrepreneurship center of Sheba Medical Center, which was filled with moments of hope, innovation, creativity, and Israeli pride in the world of Health-Tech. The data presented at the conference gives reason for optimism regarding the leading engine of the economy. Israeli high-tech proves resilience. The CEO of Israel Innovation Authority and the CEO of Startup Nation Central noted that despite Israel being at war, we experienced only a slight decrease in investments, and Israel still leads in R&D investment as a percentage of GDP, standing at 6.1%. The number of startups in the Health Tech field is particularly high, but the investment rate is lower compared to other investment areas due to the high risk. The conference leaders called for increased investments in Health-Tech companies because the ROI on successful companies is significantly higher. Congratulations to the management of Sheba Medical Center and the ARC team for their outstanding achievements and for an impressive conference with significant international presence from the worlds of Healthcare, Venture Capital, High-Tech, and Academia.

Healthcare Innovation News for the week of November 6, 2024: · JobsOhio Launches $3 Billion Ohio Discovery Corridor to Connect Innovation Districts in Columbus, Cincinnati, and Cleveland, Boosting STEM and Job Growth · CincyTech and St. Elizabeth Healthcare Forge Strategic Partnership to Propel Healthcare Innovation · Blackrock Neurotech, University of Utah startups, Partners with Noldus Information Technology to Advance Neurobehavioral Research with Integrated Neuroscience Platform · Newly Launched TikkunLev Therapeutics Advances Precision Heart Failure Therapies with Seed Funding and Strategic University of Utah Collaboration · Oracle Corporation (NYSE:ORCL) Unveils Next-Gen AI-Powered EHR System at Oracle Health Summit · Pieces Technologies Awarded $2M from National Cancer Institute (NCI) to Advance Conversational AI for Cancer Patients · Ferrum Health, Inc. Secures $16M Series A Funding Led by Foundry, with Catalyst by Wellstar and Others, to Scale Secure AI Platform in Healthcare · Praia Health, the consumer experience orchestration platform for health systems, has secured a strategic investment from the Labcorp Venture Fund Healthcare Development & Innovation Group (HDIG) Search/HDIG Partners/HDIG Funds HDIG is an ecosystem to make healthcare innovation more efficient. HDIG Search: a searchable database of hospital healthcare venture, innovation centers, tech transfer offices. It assists you in understanding the landscape of partnerships, performance, and contacts. Early-stage companies use it to find partners and funding for their pilots, or even professional firms or tech companies depending on their needs. HDIG Partners: Consulting & valuable resources for hands on insight, valuation & improvement. HDIG Funds: Capital investment into pilots & start-ups Launched with nearly 10,000 companies, hospitals, & funds, get full access for a special subscription & you can cancel at anytime, this would include building your profile. Learn more about our Acceleration Pilot Program, paid pilots, reverse studio model & other research & services. Welcome new subscriber partners: Mesolv LLC and Celebrace HDIG will be attending these events: · Ohio AI Summit – Columbus, OH, Nov. 20 · Bamberg Health Innovation – Atlanta, GA, Dec 3 · J.P. Morgan - San Francisco, Jan, 13-15 #healthcareinnovation #hospitalinnovation #innovationcenters #HDIG #venturestudios #startups

🎉Calling Scottish start-ups, spinouts and SMEs with a focus on Women’s Health! 🎉 The Accelerating Femtech programme has opened applications for its second cohort and you could be part of it!  Funded by Innovate UK and the Medical Research Council, this national programme helps start-ups, spinouts and early-stage companies to gain commercial and funding momentum. Delivered by Health Innovation Network South London, the programme will offer a blend of online and in-person support to enhance product development, entrepreneurship skills and stakeholder engagement across the NHS and academia. Participants will also be supported to prepare for a special closed-call feasibility funding opportunity through the Innovate UK Biomedical Catalyst, delivered alongside a collaborative learning programme and facilitated networking with key NHS and health sector stakeholders. Applications opened on Monday 9 September 2024 and close at midnight on Sunday 13 October 2024. You can learn more about the programme here: https://lnkd.in/epcGx_RX For Scottish-based companies: You can access additional support from Scottish Enterprise to help develop their proposals, including: 🦉 Free market research – contact research@scotent.co.uk for more information 📜Their recent report on the Femtech Economic Opportunity for Scotland (link in comments) Or message me if you're interested in a follow-on conversation #AcceleratingFemTech #Entrepreneurialism #scaling #womenshealth

European Healthtech is now approaching the growth stage after a significant rise in the last decade. A generation of startups is now reaching the growth stage, with transformative potential in anti-obesity, AI, telemedicine, physician burnout, medical imaging, personalized healthcare and more. Median deal sizes for health tech startups have doubled in a decade, but growth capital remains a critical challenge for scale-up growth. 🥈 Health & life sciences was the second most funded European industry in 2023 and proved more resilient than other segments. 💰 European VC funding in Healthtech (Digital health) reached $3.3B in 2023. Healthtech ranked 7th, with a funding decline of 38%, in line with the overall market downturn. 🔍Though digital care has historically been the most funded segment, health IT and digital pharma have been proven most resilient in recent years. ❄️ The Nordic countries are the strongest European Healthtech hubs relative to their GDP. 2️⃣ Median Healthtech deal sizes have doubled in the last 10 years. 🌱 European Healthtech is underfunded at late stage. We unpack their access to growth capital, with MTIP. Full report below 👇 Great to be working on the report with Carmel V., Patrick Glettig, Anja-Vanessa Peter from the MTIP team, and Eglantine Dupuy, Daniel Capitão and Orla Browne from Dealroom.co. As well as a huge thanks to the contributors Hélène Mathieu and Celia Pita from EIT Health, Kai Eberhardt from Oviva, Bjoern von Siemens from Caresyntax, and Nicolas Bouchet from Health Tech Hub Copenhagen for providing their time and insights for the report!

🌿 Bringing Science to Life: Key learnings from our workshop “Building a Startup in Healthcare.”🌿 Last month, our venture developers Annameta Gericke and Marta Scali facilitated the workshop "Building a Startup in Healthcare" hosted at the Salento Biomedical District in Lecce. This workshop brought together researchers, entrepreneurs, and professionals from across the health sector, all united by a common goal: to transform innovative healthtech inventions into real-world solutions. As part of our mission at NLC to bring more science to life, we are happy to share a few insights from the gathering: 𝐒𝐞𝐥𝐞𝐜𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 “𝐍𝐞𝐱𝐭 𝐁𝐢𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧” We start by identifying whether the technology addresses a significant, verified unmet medical need. Is there a recognised clinical problem that this technology aims to solve? Often the patient will recognise the problem? What is the potential impact on patient outcomes? These questions help us assess the relevance and urgency of the innovation. 𝐀𝐬𝐬𝐞𝐬𝐬𝐢𝐧𝐠 𝐭𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐟𝐞𝐚𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 Our due diligence is comprehensive, ensuring each innovation is poised to meet the market's demands. We scrutinize market size, assess regulatory pathways, and evaluate the robustness of intellectual property rights. Understanding the economic benefits for stakeholders, including hospitals, insurers, and patients, is important. 𝐄𝐧𝐠𝐚𝐠𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐞𝐱𝐩𝐞𝐫𝐭𝐬  Insights from clinical and commercial experts, along with engagement at national and international conferences, play a crucial role. These interactions provide a broader perspective on current standards, competitors, and the overall acceptance of the technology among key opinion leaders and potential users. 🔍 𝘐𝘴 𝘺𝘰𝘶𝘳 𝘪𝘯𝘷𝘦𝘯𝘵𝘪𝘰𝘯 𝘯𝘦𝘹𝘵? Do you have a healthtech innovation that could change lives? We are searching for the next big idea. Let's take it from concept to market together. For those curious to learn more about some of the upcoming workshops hosted by Italian institutions. Feel free to reach out to Marta and Annameta for more information. #NLC #knowledgesharing #healthtech #innovation #invention

Congratulations to Quantune Technologies GmbH on closing their €13.m seed round for their first-of-its-kind, noninvasive, continuous health monitoring technology.🩺✨ We are excited to announce our investment in Berlin-based Quantune Technologies GmbH, a tech bio pioneer that is reshaping health management through continuous, real-time monitoring of key biomarkers like glucose, ketones, and lactate. This breakthrough is made possible by Quantune’s patented quantum-cascade laser spectrometer, which finally allows the compression of laboratory-grade spectrometry into a wearable chip, making proactive health monitoring accessible anytime, anywhere - no blood work necessary. The implications are profound: for diabetics, athletes, and anyone aiming to take control of their health, Quantune’s technology enables personalized, preventative care. In a healthcare landscape where healthcare costs have nearly doubled over the last 20 years, but life expectancy has largely stagnated, tools like Quantune’s can drive the shift toward proactive health management. Quantune’s seed round is co-led by Vsquared Ventures and Us-based Point72 Ventures, with grants provided by the European Innovation Council and SMEs Executive Agency (EISMEA) and Investitionsbank Berlin’s ProFIT program. Congratulations to Jan F. Kischkat, Nikolaus Hahne, Oliver Supplie, Raphael Schlesinger, Hermann von Lilienfeld-Toal, and the entire Quantune team on reaching this major milestone. We’re thrilled to be part of your journey to transform healthcare from reactive to preventive. Read more about this in Marina Temkin, CFA's write-up in TechCrunch, Max Skowronek's coverage for Gründerszene, or Simon Schwarz's article in Tagesspiegel (articles linked in comments).

💉 Each year, the #WorldHealthDay, celebrated on April 7th, focuses on a specific theme or health concern, highlighting the importance of addressing key challenges to ensure the well-being of people everywhere. 🔬 Technology has become an indispensable ally in the quest for better health outcomes. From innovative #medicaldevices to groundbreaking #research, technology is revolutionizing the way we approach healthcare. ☝️Catalonia showcases a burgeoning health-tech landscape with a surge in #telemedicine adoption, cutting-edge #biomedical research, and a thriving ecosystem of #digitalhealth #startups. #Artificialintelligence is revolutionizing diagnostics, while #roboticsurgery assist surgeons in performing #surgical procedures more #precisely and less #invasively. 💡At Xartec Salut, we're proud to be part of this transformation by supporting 81 research groups from 23 institutions to drive #impactful research and development initiatives that have an impact on society. 💪 Our commitment to leveraging technology for the greater good remains unwavering. Let's continue to harness the power of #technology to build a healthier, more equitable world for all. Together, we can make a difference! #FEDERrecerca #FonsEUCat #Barcelona #HealthTech #innovation #XartecSalut #healthcareinnovation #HealthTech #Technology #innovation #startups #healthtech #startup #HealthDay #HealthTech #Innovation #HealthForAll #investors #medical #upc #engineering #research #event #creb #emprenedoria #innovation #health #business #learning #future  #medical  #research #technology #society #projects #technologytransfer #entrepeneur #healthcare #analytics #engagement #perioperative #recovery #transformation #lifesciences #entrepreneurs #startup #innovation #health #business #startup #fundraising #Catalunya Research Centre for Biomedical Engineering Universitat Politècnica de Catalunya (UPC)

🔑 𝗞𝗲𝘆 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝟮𝟬𝟮𝟯 𝗖𝗮𝘁𝗮𝗹𝗼𝗻𝗶𝗮 𝗕𝗶𝗼𝗥𝗲𝗴𝗶𝗼𝗻 𝗥𝗲𝗽𝗼𝗿𝘁: 𝗨𝗻𝗹𝗲𝗮𝘀𝗵𝗶𝗻𝗴 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹   Did you know Catalonia is one of Europe's most dynamic #healthcare hubs? In 2023, this sector continued its upward trajectory, with an 𝗮𝗻𝗻𝘂𝗮𝗹 𝗮𝘃𝗲𝗿𝗮𝗴𝗲 𝘁𝘂𝗿𝗻𝗼𝘃𝗲𝗿 (𝗖𝗔𝗚𝗥) 𝗼𝗳 𝟯.𝟴𝟭%. While historically known for its pharmaceutical prowess (concentrating 50% of Spain’s pharma industry), Catalonia’s MedTech ecosystem is now drawing attention from investors.   Here’s why MedTech enthusiasts should take note📝 𝟭. 𝗧𝗵𝗿𝗶𝘃𝗶𝗻𝗴 𝗲𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺 ✅ Of the 1,400 companies, 𝟮𝟭𝟬 𝗮𝗿𝗲 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 and 𝟮𝟭𝟮 𝗮𝗿𝗲 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵, representing 30% of the sector. These subsectors are growing fast: in 2022, 20% of new companies were MedTech, while 30% were Digital Health startups. 𝟮. 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗺𝗼𝗺𝗲𝗻𝘁𝘂𝗺 ✅ MedTech and Digital Health companies generated a substantial €𝟰,𝟮𝟳𝟯 𝗠 𝘁𝘂𝗿𝗻𝗼𝘃𝗲𝗿 in 2022. The Digital Health segment witnessed a 𝟭𝟬𝟮% 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗲 over the past 5 years. 𝟯. 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 ✅ The investment opportunities are large, with 89% of the companies in the sector being SMEs. This is confirmed by a trend of specialised investment firms established in the region and the €𝟭𝟲𝟱 𝗠 𝗶𝗻 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 raised by MedTech and Digital Health startups in 2023. 𝟰. 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 ✅ Catalonia ranks 𝟱𝘁𝗵 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲 𝗮𝗻𝗱 𝟴𝘁𝗵 𝗪𝗼𝗿𝗹𝗱𝘄𝗶𝗱𝗲 when it comes to participating in Clinical Trials, and 88,5% of the Clinical trials in Spain were conducted in the region. 𝟱. 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗽𝗶𝗽𝗲𝗹𝗶𝗻𝗲 ✅ The HealthTech pipeline predominantly comprises 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 (𝟲𝟲%), including 𝟲% 𝗜𝗻 𝗩𝗶𝘁𝗿𝗼 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 (𝗜𝗩𝗗𝘀). Around 60% of these products have undergone pilot tests or demonstrated proof of concept. 𝟲. 𝗔𝗜 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻✅𝟭𝟯% 𝗼𝗳 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀 are applying AI to their products are MedTech companies. From accelerated drug discovery to personalised medicine, AI is transforming healthcare.   📊 𝗗𝗮𝘁𝗮 𝗦𝗼𝘂𝗿𝗰𝗲: Information extracted from the Biocat, BioRegion of Catalonia 2023 Report. Dive deeper into the numbers and trends shaping MedTech innovation here 👉 https://lnkd.in/dAmM9s87   #BioRegionReport #Healthcare #Innovation #Medtech